EU drugs agency: swine flu vaccine data "promising"
Key points
- Early clinical trial results suggest that swine flu vaccines now being rushed through development produce a strong immune response, suggesting they should work well, the head of Europe's drugs watchdog said on Thursday.
- "It seems to be quite promising," Thomas Lonngren, executive director of the European Medicines Agency (EMEA), told reporters.
- "The immune response to all these vaccines is a very high response, whatever type of vaccine it is, whether it is adjuvanted or non-adjuvanted," he added.
- Adjuvants are substances added to vaccines to boost their effectiveness.
Early clinical trial results suggest that swine flu vaccines now being rushed through development produce a strong immune response, suggesting they should work well, the head of Europe's drugs watchdog said on Thursday.
"It seems to be quite promising," Thomas Lonngren, executive director of the European Medicines Agency (EMEA), told reporters.
"The immune response to all these vaccines is a very high response, whatever type of vaccine it is, whether it is adjuvanted or non-adjuvanted," he added.
Adjuvants are substances added to vaccines to boost their effectiveness.
The EMEA's expert committee on new medicines will consider the first three H1N1 swine flu vaccines from GlaxoSmithKline , Novartis and Baxter at its next meeting during the week commencing Sept. 21.
If all goes well, the first swine flu vaccines could be licensed by the European Commission early in October, Lonngren said.
LONDON (Reuters)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →NewsCurrent HPV vaccine may not help some women with immune problems
Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being…
8 April 2013
NewsResearchers find potential map to more effective HIV vaccine
By tracking the very earliest days of one person's robust immune response to HIV, researchers have charted a new route for developing a long-sought vaccine that could boost the body's ability to neutralize the virus.…
4 April 2013
NewsStudy offers new way to discover HIV vaccine targets
Decades of research and three large-scale clinical trials have so far failed to yield an effective HIV vaccine, in large part because the virus evolves so rapidly that it can evade any vaccine-induced immune response.…
22 March 2013
